Human Metabolome Technologies (TSE:6090) Other Stockholders Equity: 円-20.5 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6090 Human Metabolome Technologies Inc TSE:6090
60 GF Score
Price 円585.00
GF Value 円530.59
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Human Metabolome Technologies Other Stockholders Equity?

Human Metabolome Technologies TSE:6090 -0.85% 60 Other Stockholders Equity is 円-20.5 Mil as of Dec. 2025. GuruFocus rates TSE:6090 with a GF Score™ of 60/100 and a GF Value™ of 円530.59 (Fairly Valued). The stock has 4 warning signs investors should review.

Human Metabolome Technologies's Other Stockholders Equity for the quarter that ended in Dec. 2025 was 円-20.5 Mil.

Human Metabolome Technologies's quarterly Other Stockholders Equity declined from Jun. 2025 (円-6.2 Mil) to Sep. 2025 (円-22.4 Mil) but then increased from Sep. 2025 (円-22.4 Mil) to Dec. 2025 (円-20.5 Mil).

Human Metabolome Technologies's annual Other Stockholders Equity declined from Jun. 2022 (円57.7 Mil) to Jun. 2023 (円51.6 Mil) and declined from Jun. 2023 (円51.6 Mil) to Jun. 2024 (円35.7 Mil).

Human Metabolome Technologies Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Human Metabolome Technologies's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Human Metabolome Technologies Other Stockholders Equity Chart

Human Metabolome Technologies Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 115.43 99.08 57.74 51.64 35.72

Human Metabolome Technologies Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.24 -6.18 -22.39 -20.53 -19.93
TSE:6090
60GF Score
Human Metabolome Technologies Inc TSE:6090
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Human Metabolome Technologies Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of 円-20.5 Mil mean?
Human Metabolome Technologies (TSE:6090) has a Other Stockholders Equity of 円-20.5 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Human Metabolome Technologies and its competitors.
Is Human Metabolome Technologies' Other Stockholders Equity too high?
Human Metabolome Technologies' current Other Stockholders Equity is 円-20.5 Mil. Overall, Human Metabolome Technologies has a GF Score™ of 60/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Human Metabolome Technologies' Other Stockholders Equity compare to TMO and DHR?
Human Metabolome Technologies' Other Stockholders Equity of 円-20.5 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Diagnostics & Research company?
A good Other Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Human Metabolome Technologies and its competitors. Human Metabolome Technologies's current Other Stockholders Equity is 円-20.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Human Metabolome Technologies stock overvalued right now?
Based on GuruFocus' analysis, Human Metabolome Technologies (TSE:6090) is currently considered Fairly Valued. The stock's GF Value™ is 円530.59, compared to a current price of 円585.00 — trading 10.3% above its estimated fair value. The current Other Stockholders Equity is 円-20.5 Mil. Human Metabolome Technologies' overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Human Metabolome Technologies (TSE:6090), the current Other Stockholders Equity is 円-20.5 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Human Metabolome Technologies (TSE:6090) Overvalued in 2026?

Based on GuruFocus' analysis, Human Metabolome Technologies stock appears to be overvalued. The current stock price of 円585.00 is trading 10.3% above its estimated GF Value™ of 円530.59. GuruFocus considers Human Metabolome Technologies to be Fairly Valued.

Key valuation signals for TSE:6090:

  • Other Stockholders Equity: 円-20.5 Mil
  • GF Value™: 円530.59 vs. price of 円585.00 (10.3% above fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the TSE:6090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Human Metabolome Technologies Business Description

Address Yamagata Prefecture Kakuganji Water 246-2, Tsuruoka, JPN, 997-0052
Human Metabolome Technologies Inc is involved in the search and diagnosis of biomarkers and commercialization in the field of drug development.
60GF Score

Get the complete analysis for TSE:6090

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円585.00
Price
円530.59
GF Value